These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 26871671)
1. Mucking around in the Genome: MUC5B in Idiopathic Pulmonary Fibrosis. Kolb M; White ES; Gauldie J Am J Respir Crit Care Med; 2016 Feb; 193(4):355-7. PubMed ID: 26871671 [No Abstract] [Full Text] [Related]
2. MUC5B Promoter Variant rs35705950 Affects MUC5B Expression in the Distal Airways in Idiopathic Pulmonary Fibrosis. Nakano Y; Yang IV; Walts AD; Watson AM; Helling BA; Fletcher AA; Lara AR; Schwarz MI; Evans CM; Schwartz DA Am J Respir Crit Care Med; 2016 Feb; 193(4):464-6. PubMed ID: 26871673 [No Abstract] [Full Text] [Related]
5. Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways. Schwartz DA Ann Am Thorac Soc; 2018 Nov; 15(Suppl 3):S192-S197. PubMed ID: 30431344 [TBL] [Abstract][Full Text] [Related]
6. The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering Zhang Q; Wang Y; Qu D; Yu J; Yang J Biomed Res Int; 2019; 2019():9712464. PubMed ID: 31309122 [TBL] [Abstract][Full Text] [Related]
7. Regulation of MUC5B Expression in Idiopathic Pulmonary Fibrosis. Helling BA; Gerber AN; Kadiyala V; Sasse SK; Pedersen BS; Sparks L; Nakano Y; Okamoto T; Evans CM; Yang IV; Schwartz DA Am J Respir Cell Mol Biol; 2017 Jul; 57(1):91-99. PubMed ID: 28272906 [TBL] [Abstract][Full Text] [Related]
8. Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs. Conti C; Montero-Fernandez A; Borg E; Osadolor T; Viola P; De Lauretis A; Stock CJ; Bonifazi M; Bonini M; Caramori G; Lindahl G; Blasi FB; Nicholson AG; Wells AU; Sestini P; Renzoni E Am J Respir Crit Care Med; 2016 Feb; 193(4):462-4. PubMed ID: 26871672 [No Abstract] [Full Text] [Related]
9. A common MUC5B promoter polymorphism and pulmonary fibrosis. Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741 [TBL] [Abstract][Full Text] [Related]
10. Interaction between the promoter Stock CJ; Conti C; Montero-Fernandez Á; Caramori G; Molyneaux PL; George PM; Kokosi M; Kouranos V; Maher TM; Chua F; Rice A; Denton CP; Nicholson AG; Wells A; Sestini P; Renzoni EA Thorax; 2020 Oct; 75(10):901-903. PubMed ID: 32580994 [TBL] [Abstract][Full Text] [Related]
11. MUC5B Promoter Polymorphism and Survival in Indian Patients With Idiopathic Pulmonary Fibrosis. Dhooria S; Bal A; Sehgal IS; Prasad KT; Kashyap D; Sharma R; Muthu V; Agarwal R; Aggarwal AN Chest; 2022 Oct; 162(4):824-827. PubMed ID: 35405109 [No Abstract] [Full Text] [Related]
12. MUC5B and Idiopathic Pulmonary Fibrosis. Yang IV; Fingerlin TE; Evans CM; Schwarz MI; Schwartz DA Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S193-9. PubMed ID: 26595739 [TBL] [Abstract][Full Text] [Related]
13. The Platenburg MGJP; Wiertz IA; van der Vis JJ; Crestani B; Borie R; Dieude P; Kannengiesser C; Burgers JA; Grutters JC; van Moorsel CHM Eur Respir J; 2020 Apr; 55(4):. PubMed ID: 31949121 [No Abstract] [Full Text] [Related]
14. A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. Zhang Y; Noth I; Garcia JG; Kaminski N N Engl J Med; 2011 Apr; 364(16):1576-7. PubMed ID: 21506748 [No Abstract] [Full Text] [Related]
15. MUC5B: a good target for future therapy in pulmonary fibrosis? Mahida R; Turner AM Thorax; 2013 May; 68(5):401. PubMed ID: 23329274 [No Abstract] [Full Text] [Related]
17. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. Peljto AL; Zhang Y; Fingerlin TE; Ma SF; Garcia JG; Richards TJ; Silveira LJ; Lindell KO; Steele MP; Loyd JE; Gibson KF; Seibold MA; Brown KK; Talbert JL; Markin C; Kossen K; Seiwert SD; Murphy E; Noth I; Schwarz MI; Kaminski N; Schwartz DA JAMA; 2013 Jun; 309(21):2232-9. PubMed ID: 23695349 [TBL] [Abstract][Full Text] [Related]
18. Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias. van der Vis JJ; Snetselaar R; Kazemier KM; ten Klooster L; Grutters JC; van Moorsel CH Respirology; 2016 May; 21(4):712-7. PubMed ID: 26699835 [TBL] [Abstract][Full Text] [Related]
19. Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice. Hancock LA; Hennessy CE; Solomon GM; Dobrinskikh E; Estrella A; Hara N; Hill DB; Kissner WJ; Markovetz MR; Grove Villalon DE; Voss ME; Tearney GJ; Carroll KS; Shi Y; Schwarz MI; Thelin WR; Rowe SM; Yang IV; Evans CM; Schwartz DA Nat Commun; 2018 Dec; 9(1):5363. PubMed ID: 30560893 [TBL] [Abstract][Full Text] [Related]
20. CT Imaging Phenotypes of Pulmonary Fibrosis in the MUC5B Promoter Site Polymorphism. Chung JH; Peljto AL; Chawla A; Talbert JL; McKean DF; Rho BH; Fingerlin TE; Schwarz MI; Schwartz DA; Lynch DA Chest; 2016 May; 149(5):1215-22. PubMed ID: 26836909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]